CARNUCCIO, ROSA
 Distribuzione geografica
Continente #
EU - Europa 5.555
AS - Asia 5.298
NA - Nord America 4.985
SA - Sud America 547
AF - Africa 124
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 5
Totale 16.524
Nazione #
US - Stati Uniti d'America 4.791
SG - Singapore 2.468
IT - Italia 2.426
RU - Federazione Russa 1.507
CN - Cina 935
VN - Vietnam 915
BR - Brasile 432
HK - Hong Kong 419
FR - Francia 256
NL - Olanda 228
UA - Ucraina 213
DE - Germania 195
FI - Finlandia 190
IE - Irlanda 173
CA - Canada 121
IN - India 119
GB - Regno Unito 115
JP - Giappone 104
SE - Svezia 69
BD - Bangladesh 52
AR - Argentina 50
MX - Messico 42
ZA - Sudafrica 39
TR - Turchia 36
PL - Polonia 34
IQ - Iraq 30
ES - Italia 28
TH - Thailandia 26
PK - Pakistan 24
PH - Filippine 23
ID - Indonesia 22
CH - Svizzera 21
EC - Ecuador 21
KR - Corea 21
CI - Costa d'Avorio 18
IR - Iran 17
CZ - Repubblica Ceca 15
TW - Taiwan 15
LT - Lituania 12
TN - Tunisia 12
EG - Egitto 10
RS - Serbia 10
AT - Austria 9
CO - Colombia 9
NP - Nepal 9
SA - Arabia Saudita 9
AU - Australia 8
MA - Marocco 8
PY - Paraguay 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
JM - Giamaica 7
JO - Giordania 7
KE - Kenya 7
RO - Romania 7
UY - Uruguay 7
AL - Albania 6
BE - Belgio 6
DZ - Algeria 6
GR - Grecia 6
KZ - Kazakistan 6
LU - Lussemburgo 6
CL - Cile 5
PE - Perù 5
VE - Venezuela 5
GT - Guatemala 4
MD - Moldavia 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
EU - Europa 3
IL - Israele 3
MY - Malesia 3
PS - Palestinian Territory 3
AZ - Azerbaigian 2
BB - Barbados 2
BF - Burkina Faso 2
BG - Bulgaria 2
BH - Bahrain 2
BS - Bahamas 2
GF - Guiana Francese 2
LV - Lettonia 2
MN - Mongolia 2
NI - Nicaragua 2
NO - Norvegia 2
QA - Qatar 2
RW - Ruanda 2
SI - Slovenia 2
TG - Togo 2
UG - Uganda 2
AM - Armenia 1
AO - Angola 1
BY - Bielorussia 1
BZ - Belize 1
CD - Congo 1
CV - Capo Verde 1
Totale 16.496
Città #
Singapore 1.095
San Jose 824
Hong Kong 402
Chandler 364
Moscow 350
Ashburn 339
Beijing 304
Ho Chi Minh City 262
Jacksonville 206
The Dalles 200
Hanoi 199
Millbury 186
Princeton 163
Naples 146
Santa Clara 146
Lauterbourg 141
Rome 134
Amsterdam 115
Nanjing 113
Los Angeles 108
Boston 99
Seattle 98
Tokyo 94
Wilmington 83
Buffalo 82
Milan 77
New York 74
Napoli 57
Dallas 51
Woodbridge 51
Ottawa 50
Munich 44
Cagliari 42
São Paulo 41
Da Nang 40
Redondo Beach 40
Florence 37
Haiphong 33
Orem 33
Bologna 32
Nanchang 32
Brooklyn 31
Council Bluffs 31
Hebei 30
Montreal 29
Tianjin 29
Bari 28
Shenyang 27
Warsaw 26
Turin 24
Biên Hòa 22
Catania 22
Des Moines 22
Houston 22
Chennai 21
Chicago 21
Hefei 21
Ann Arbor 20
London 20
San Francisco 20
Denver 18
Palermo 18
Pune 18
Changsha 17
Falls Church 17
Kronberg 17
Mexico City 17
Norwalk 17
Catanzaro 16
Dong Ket 16
Ferrara 16
Frankfurt am Main 16
Salerno 16
Toronto 16
Turku 16
Jiaxing 15
Brescia 14
Brno 14
Bangkok 13
Caserta 13
Hải Dương 13
Mumbai 13
Verona 13
Helsinki 12
Atlanta 11
Baghdad 11
Boardman 11
Johannesburg 11
Manchester 11
New Delhi 11
Padova 11
Rio de Janeiro 11
Zurich 11
Curitiba 10
Orange 10
Phoenix 10
Poplar 10
Shanghai 10
Torino 10
Can Tho 9
Totale 7.992
Nome #
Etosomi e transferosomi per la veicolazione topica del resveratrolo. 2.026
Etosomi e transferosomi per la veicolazione topica del resveratrolo 579
Sviluppo di nuovi gel fisici a base di chitosano per il trattamento di piaghe da decubito. 180
Ruolo dei fattori trascrizionali NF-kB, IRF-1 e STAT1 nell’induzione del gene della iNOS da parte di gliadina ed IFN- in macrofagi RAW 264.7 177
Transferosomes and ethosomes for the trans-resveratrol permeation through the skin: a comparative study. 165
Novel Non-Peptide Small Molecules Preventing IKKβ/NEMO Association Inhibit NF-κB Activation in LPS-Stimulated J774 Macrophages 155
Design and characterization of a chitosan physical gel promoting wound healing in mice. 149
Transcription factor decoy oligonucleotides to nuclear factor-κB inhibits reverse passive Arthus reaction in rat. 139
NF-kappaB regulates cell survival in chronic granulomatous inflammation. 134
Biodegradable particles for local and prolonged delivery of an oligonucleotide decoy to nuclear factor-kB in the lung 134
Adenosine A2A Receptor Agonist, 2-p-(2-Carboxyethyl)phenethylamino-5′-N-ethylcarboxamidoadenosine hydrochloride hydrate (CGS21680), Inhibits Inflammation and Increases Fibroblast Growth Factor 2 (FGF-2) Tissue Expression in Carrageenan Induced Rat Paw Edema. 134
Role of nuclear factor-kappaB in a rat model of vascular injury. 133
BIOACTIVE PHYSICAL CHITOSAN-BASED GELS FOR WOUND HEALING 132
Delivery of a decoy oligonucleotide against NF-??B by new cationic liposomes 129
Development of new physical gels based on chitosan for wound healing. 127
Hydroxytyrosol, a phenolic compound from virgin olive oil, prevents macrophage activation. 126
Effect of Hyaluronic Acid on the Thermogelation and Biocompatibility of its blends with Methyl Cellulose 126
Improving therapy of lung inflammation by inhalable powders for prolonged release of a decoy oligonucleotide against NF-kB 126
In situ forming gel fo wound healing 124
5,6-Dihydroxyindole-2-carboxylic acid, a diffusible melanin precursor, is a potent stimulator of lipopolysaccharide-induced production of nitric oxide by J774 macrophages 121
Structure and absolute stereochemistry of the new cyclolinteinol and cyclolinteinol acetate, macrophage activation modulators 119
Anti-inflammatory activity of macrolide antibiotics. 118
Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on ΔF508 cystic fibrosis transmembrane conductance regulator 117
Development of new physical gels based on chitosan for wound healing. 116
The IkB Kinase Inhibitor, NEMO-binding Domain Peptide, inhibits rat balloon injury-induced neointimal formation. 114
Neutralization of IL-18 inhibits balloon-injury-induced neointimal formation. 112
Gliadina ed espressione del gene della iNOS: ruolo di NF-kB, IRF-1 e STAT-1 alfa. 112
Enhanced antioxidant effect of trans-resveratrol: potential of binary systems with polyethylene glycol and cyclodextrin. 112
The role of NF-kappaB, IRF-1, STA-1alpha transcription factors in the iNOS gene induction by gliadin and IFN-gamma in RAW 264.7 macrophages. 111
Disease-relevant proteostasis regulation of cystic fibrosis transmembrane conductance regulator. 111
Local administration of WIN 55,212-2 reduces chronic granuloma-associated angiogenesis in rat by inhibiting NF-kappaB activation 110
A new antiproliferative sulfated alkene from the mediterranean tunicate Microcosmus vulgaris 110
Neutralization of Interleukin-18 Inhibits Neointimal Formation in a Rat Model of Vascular Injury. 110
The role of NF-kappaB, IRF-1, and STAT-1alpha transcription factors in the iNOS gene induction by gliadin and IFN-gamma in RAW 264.7 macrophages. 110
Neutralization of IL-18 inhibits injury-induced neointima formation. 109
Respirable large porous particles for local and prolonged delivery of an oligonucleotide decoy to Nuclear Factor-kB: in vitro/in vivo potential in cystic fibrosis 109
Nanocarriers for topical administration of resveratrol: a comparative study 108
LIPOCORTIN AND VASOCORTIN: TWO SPECIES OF GLUCOCORTICOID INDUCED PROTEINS AFFECTING VASCULAR PERMEABILITY. 107
Nuovi liposomi cationici per la veicolazione di oligonucleotidi. 106
Inhibition of nuclear factor-kB activation prevents the loss of vascular tone in LPS-treated rats. 104
Novel chitosan gel for wound healing: thermal, rheological, in vitro drug release and biocompatibility properties 104
Nitric oxide-induced endoplasmic reticulum stress activates the expression of cargo receptor proteins and alters the glycoprotein transport to the Golgi complex 104
Macrophage Autophagy in Atherosclerosis 104
Oxalomalate affects the inducible nitric oxide synthase expression and activity 102
Transferosomes and ethosomes for the trans-resveratrol permeation through the skin: a comparative study 101
The IkB kinase inhibitor nuclear factor-kB essential modulator-binding domain peptide for inhibition of injury-induced neointimal formation. 100
Inhalable large porous particles for local and prolonged devlivery an oligonucleotide decoy to NF-??B in cystic fibrosis 100
NF-kappaB is activated in intestinal mucosa of coeliac patients. 99
Control of autophagy by oncogenes and tumor suppressor genes 99
PEI-Engineered Respirable Particles Delivering a Decoy Oligonucleotide to NF-kB: Inhibiting MUC2 Expression in LPS-Stimulated Airway Epithelial Cells 99
A new approach for cystic fibrosis treatment: large porous particles for local and prolonged delivery of an oligonucleotide decoy to Nuclear Factor-kB in the lung 98
Inhibition of iNOS protein expression by decoy ODN against NF-kappaB released from PLGA microspheres and naked ODN in activated macrophages. 97
Inflammatory events in a vascular remodeling model induced by surgical injury to the rat carotid artery. 96
Porrigenins A and B, novel cytotoxic and antiproliferative sapogenins isolated from Allium porrum 96
Synthesis and Pharmacological Evaluation of Modified Adenosines Joined to Mono-Functional Platinum Moieties 96
Palmitoylethanolamide controls rMCP-5 activity by the regulation of microphtalmia-associated transcription factor. 95
Activation of nuclear transcription factor kappaB in rat carrageenin-induced pleurisy. 94
Novel antiproliferative Alkyl sulfates from the Mediterranean tunicate Ascidia mentula 93
Evidence that mast cell degranulation, histamine and tumour necrosis factor alpha release occurin LPS-induced plasma leakage in rat skin 93
Enhanced intracellular uptake and inhibition of NF-kappaB activation by decoy oligonucleotide released from PLGA microspheres. 92
Characterization of vasocortin-like proteins induced by dexamethasone in endothelial cells. 92
Inhibition of NF-kappaB activation by decoy ODN released from liposomes in activated macrophages. 92
Transcription factor decoy oligodeoxynucleotides to nuclear factor-kappaB inhibits reverse passive Arthus reaction in rat. 91
Ultraflexible liposomes for topical delivery of resveratrol 91
Antihistaminic activity of the alkaloids isolated from Caribbean Agelas sponges. 90
Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement 90
Engineering inhalable particles for local and prolonged delivery of an oligonucleotide decoy to nuclear factor-kb 90
PLGA microspheres for the delivery of oligonucleotides. 90
Nanocarriers for topical delivery of resveratrol. 90
Effects of Hydroxytyrosol on Macrophage Activation 89
12-Keto-Porrigenin and the Unique 2,3-Seco-Porrigenin, New Antiproliferative Sapogenins isolated from Allium porrum. 88
. Liposomi a base di un nuovo lipide cationico per il rilascio di un oligonucleotide decoy contro il fattore di trascrizione NF-kappaB. 88
Activation of nuclear factor-kB in rat carrageenin-induced pleurisy. 87
NFkappaB decoy oligonucleotides. 87
Antiproliferative sesterterpenes from the Caribbean sponge Cacospongia cf. linteiformis. 87
NF-kB decoy ODN released from respirable and biodegradable PEI/PLGA particles inhibits MUC2 expression in LPS-stimulated human lung cells 87
Cyclolinteinone, a sesterterpene from sponge Cacospongia linteiformis, prevents inducible nitric oxide synthase and inducible cyclo-oxygenase protein expression by blocking nuclear factor-kappaB activation in J774 macrophages. 86
Microspheres for the sustained release of an ODN decoy to NF-kB in rat model of chronic inflammation 86
Sustained inhibition of IL-6 and IL-8 expression by decoy ODN to NF-??B delivered through respirable large porous particles in LPS-stimulated cystic fibrosis bronchial cells. 86
Microsfere di PLGA per il rilascio controllato di un oligonucleotide decoy per NF-kappaB. 86
Oligonucleotide decoy to NF-kappaB slowly released from PLGA microspheres reduces chronic inflammation in rat. 85
Novel physical chitosan gel: in vivo evidence of its potential in wound healing 85
Nuclear factor-kappaB regulates inflammatory cell apoptosis and phagocytosis in rat carrageenin-sponge implant model. 84
Nuclear factor-kappaB is activated in small intestinal mucosa of celiac patients. 83
Nuclear factor-kB activation mediates the expression of inducible isoforms of nitric oxide synthase and cyclooxygenase in a rat model of vascular injury. 83
Novel particulate systems for the delivery of an oligonucleotide decoy to Nuclear Factor-kappaB: a potential strategy for treating cystic fibrosis 83
L'agelongina inibisce la produzione di NO e l'espressione della iNOS in cellule di glioma di ratto C6 stimolate con LPS ed IFN-gamma 83
Different strategy for an efficient delivery of an oligonucleotide decoy to NF-kappaB. 83
Palmitoylethanolamide inhibits rMCP-5 expression by regulating MITF activation in rat chronic granulomatous inflammation 83
The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells 82
INVOLVEMENT OF NF-KB IN THE REGULATION OF CYCLOOXIGENASE-2 PROTEIN EXPRESSION IN LPS-STIMULATED J774 MACROPHAGES. 81
Nuclear factor-kB activation mediates inducible nitric oxide synthase expression in carrageenin-induced pleurisy. 80
Lipocortins 80
Polyethylenimine-engineered respirable particles delivering a decoy oligonucleotide to NF-B: a novel combination therapy for cystic fibrosis? PROGEJT FFC#23_2011 80
A Decoy Oligonucleotide to NF-κB Delivered through Inhalable Particles Prevents LPS-Induced Rat Airway Inflammation. 80
Liposomi cationici per il rilascio di un oligonucleotide decoy contro il fattore di trascrizione NF-kappaB 79
Nanomaterials toxicity and cell death modalities. 79
A decoy oligonucleotide to NF-κB delivered through inhalable particles inhibits the lung inflammation induced by LPS in rat 78
New cytotoxic steroids from the marine sponge Dysidea fragilis coming from the lagoon of Venice 77
Gliadin increases iNOS protein expression in activated macrophages. 77
Totale 12.701
Categoria #
all - tutte 50.940
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.940


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202142 0 0 0 0 0 0 0 0 0 0 0 42
2021/20221.068 16 9 22 29 16 35 41 53 198 105 140 404
2022/20231.152 195 104 42 73 120 95 35 107 127 118 80 56
2023/20241.152 54 100 149 76 66 119 65 144 30 41 227 81
2024/20253.869 299 161 42 99 128 177 469 231 319 405 1.210 329
2025/20267.102 834 415 628 625 1.259 307 970 410 894 514 184 62
Totale 16.720